טוען...
Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis
Activation of antigen-specific T-lymphocyte responses may be needed to cure disorders caused by chronic infection with low-risk human papillomavirus (lrHPV). Safe and effective adjuvant therapies for such disorders are needed. The safety and efficacy of a novel gorilla adenovirus vaccine expressing...
שמור ב:
| הוצא לאור ב: | NPJ Vaccines |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group UK
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8213691/ https://ncbi.nlm.nih.gov/pubmed/34145272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-021-00348-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|